https://twitter.com/VigilantFox/status/1776023843888415125
The Vigilant Fox 🦊
@VigilantFox
100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study
Dr. Andrea Cercek, one of the lead researchers, said:
“It’s absolutely incredible … We’ve certainly never seen this before.”
All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.
This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.
The authors wrote:
“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging … and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”
How does this monoclonal antibody actually work?
Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.
Rate proposed Community Notes
12:07 PM · Apr 4, 2024